ArticleOncogene2019

circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.

Yiran Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.